Literature DB >> 24126013

Pre-exposure prophylaxis against rabies in children: safety of purified chick embryo cell rabies vaccine (Vaxirab N) when administered by intradermal route.

Haradanahalli S Ravish1.   

Abstract

WHO recommends that children living in highly endemic regions be considered for pre-exposure prophylaxis with rabies vaccine, since they will be at continual, frequent or increased risk of exposure to the animal bites. The recommendations will come from WHO only after it has been proven by many previous scientific studies among children which have shown that pre-exposure prophylaxis using Purified Chick Embryo Cell Vaccine (PCECV) is safe and well tolerated. This has been mentioned in the discussion. The authors have not claimed/nor assumed in any part of their manuscript that they are the first to demonstrate the safety of purified chick embryo cell rabies vaccine when administered by intradermal route for pre-exposure prophylaxis against rabies in children.

Entities:  

Keywords:  children; intradermal rabies vaccination; pre-exposure prophylaxis; purified chick embryo cell rabies vaccine; rabies

Mesh:

Substances:

Year:  2013        PMID: 24126013      PMCID: PMC4185904          DOI: 10.4161/hv.26756

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  4 in total

1.  Pre-exposure rabies vaccination using purified chick embryo cell rabies vaccine intradermally is immunogenic and safe.

Authors:  Thavatchai Kamoltham; Wirawan Thinyounyong; Phana Phongchamnaphai; Phran Phraisuwan; Pakamatz Khawplod; Angelika Banzhoff; Claudius Malerczyk
Journal:  J Pediatr       Date:  2007-08       Impact factor: 4.406

2.  Randomised feasibility trial of pre-exposure rabies vaccination with DTP-IPV in infants.

Authors:  J Lang; G H Duong; V G Nguyen; T T Le; C V Nguyen; V Kesmedjian; S A Plotkin
Journal:  Lancet       Date:  1997-06-07       Impact factor: 79.321

3.  Safety and Immunogenicity of purified chick embryo cell rabies vaccine (VaxiRab N) administered intradermally as post exposure prophylaxis.

Authors:  Hardanahalli S Ravish; Veena Vijayashankar; Shampur N Madhusudana; Mysore K Sudarshan; Doddabele Ha Narayana; Gangaboraiah Andanaiah; Belludi Y Ashwin; Annadani R Rachana; Manjula Shamanna
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

4.  Protecting Indian schoolchildren against rabies: pre-exposure vaccination with purified chick embryo cell vaccine (PCECV) or purified verocell rabies vaccine (PVRV).

Authors:  Preeti Shanbag; Nitin Shah; Madhuri Kulkarni; Manisha Juvekar; S N Madhusudana; Hoshang B Vakil; Claudius Malerczyk
Journal:  Hum Vaccin       Date:  2008-10-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.